Drug interaction considerations GLP-1 medications can affect gastric emptying and may alter the absorption of oral medications taken at the same time
Glucagon-like peptide-1 (GLP-1), as one of the important targets for the treatment of type 2 diabetes mellitus (T2DM), has obvious therapeutic effect, short half-life and easy to be cleared
PubMed Goldstein, A.L., Hannappel, E., Sosne, G., & Kleinman, H.K
A key trial found that 600mg per day provided the best balance of effectiveness and tolerability, reducing instances of nausea, dizziness, and GI discomfort.4 A separate review of multiple studies supports this, concluding that 600mg daily is effective and well-tolerated for conditions like diabetic neuropathy, insulin resistance, and oxidative stress.5 That body of research has established 600mg of racemic ALA as a standard dose in clinical studies, thanks to its consistent balance of efficacy and tolerability
One may have a history that makes a specific drug a poor fit
The main distinction between the two is based on their structure and longevity